PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.99%
Revenue growth at 75-90% of META's 4.54%. Bill Ackman would push for innovation or market expansion to catch up.
5.93%
Gross profit growth at 75-90% of META's 6.76%. Bill Ackman would demand operational improvements to match competitor gains.
-0.03%
Negative EBIT growth while META is at 8.44%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.03%
Negative operating income growth while META is at 8.44%. Joel Greenblatt would press for urgent turnaround measures.
-28.94%
Negative net income growth while META stands at 132.84%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-29.17%
Negative EPS growth while META is at 131.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-28.17%
Negative diluted EPS growth while META is at 132.97%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.17%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.25%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
22.48%
OCF growth above 1.5x META's 8.03%. David Dodd would confirm a clear edge in underlying cash generation.
34.35%
FCF growth above 1.5x META's 15.92%. David Dodd would verify if the firm’s strategic investments yield superior returns.
522.31%
10Y revenue/share CAGR under 50% of META's 1481.69%. Michael Burry would suspect a lasting competitive disadvantage.
139.50%
5Y revenue/share CAGR under 50% of META's 404.64%. Michael Burry would suspect a significant competitive gap or product weakness.
79.01%
3Y revenue/share CAGR at 50-75% of META's 156.16%. Martin Whitman would question if the firm lags behind competitor innovations.
418.27%
10Y OCF/share CAGR under 50% of META's 1308.11%. Michael Burry would worry about a persistent underperformance in cash creation.
152.12%
Below 50% of META's 582.88%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
55.89%
3Y OCF/share CAGR under 50% of META's 164.73%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
293.93%
Below 50% of META's 2193.71%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
152.15%
Below 50% of META's 595.44%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
38.59%
Below 50% of META's 136.53%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
428.15%
Equity/share CAGR of 428.15% while META is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
92.80%
Below 50% of META's 305.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
44.27%
3Y equity/share CAGR at 50-75% of META's 76.73%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.11%
Firm’s AR is declining while META shows 2.13%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
45.33%
Inventory growth of 45.33% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
2.31%
Asset growth well under 50% of META's 6.33%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.62%
Under 50% of META's 5.96%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.45%
Debt shrinking faster vs. META's 16.93%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
5.49%
R&D growth drastically higher vs. META's 7.03%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
15.11%
We expand SG&A while META cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.